Qid® is the world’s first microtransponder for clinical use in a breast implant. It is the only transponder with a CE mark (which indicates compliance with the health, safety, and environmental protection standards for products sold in the European Economic Area), and the United States Food & Drug Administration (FDA) cleared it for use in 2004. Qid® is placed in the gel filling inside Motiva® Implants.
A handheld reader is used to externally scan the transponder, providing an electronic serial number (ESN) that can be used to retrieve important implant information such as manufacturing date, implant type, volume, and more.
Qid® is an optional feature in Motiva® Implants that is particularly useful to patients and surgeons to identify the implant type after the surgery, and to verify implant details during the event of a product recall.
Product information or warranty on cards can be lost or misplaced. With its unique ESN permanently located within the breast implant, Qid® provides the confidence of instant implant traceability and verification.
A radio frequency identification (RFID) microtransponder (Qid®) is a passive component (without a battery) placed in the gel that provides each implant device with a unique electronic serial number which is only accessible through the use of a handheld scanner specific to Motiva. The Electronic serial number does not contain patient-specific or identifiable information, only device-specific information such as the manufacturing date, serial number, lot number, implant volume, size and projection, model and surface type).
The Qid is 9mm in length.
The components of the Qid® are:
- Copper Polystermide Estersol 180 wire,
- Nickel-Zinc Ferrite core,
- Photobond4442 Acrylate adhesive,
- 4305 Application Specific Integrated Circuit (ASIC),
- and Soda-lime Silicate glass.
